Bioresorbable vascular scaffolds technology: current use and future developments by Giacchi G, Ortega-Paz L, Brugaletta S, Ishida K, Sabaté M

Get full text

Effect of COVID-19 vaccines on post-COVID cardiac and thromboembolic complications by Mercadé Besora, N, Prieto-Alhambra, D, Roel, E, Delmestri, A, Prats, C, Jodicke, AM, Catala Sabate, M

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry. by Sabaté, M, Brugaletta, S, Abizaid, A, Banning, A, Bartorelli, A, Džavík, V, Ellis, S, Holmes, D, Gao, R, Jeong, M, Legrand, V, Neumann, F, Nyakern, M, Spaulding, C, Stoll, H, Worthley, S, Urban, P

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry by Sabaté, M, Brugaletta, S, Abizaid, A, Banning, A, Bartorelli, A, Džavík, V, Ellis, S, Holmes, D, Gao, R, Jeong, M, Legrand, V, Neumann, F, Nyakern, M, Spaulding, C, Stoll, H, Worthley, S, Urban, P

Bypass surgery or stenting for left main coronary artery disease in patients with diabetes by Milojevic, M, Serruys, P, Sabik, J, Kandzari, D, Schampaert, E, Van Boven, A, Horkay, F, Ungi, I, Mansour, S, Banning, A, Taggart, D, Sabaté, M, Gershlick, A, Bochenek, A, Pomar, J, Lembo, N, Noiseux, N, Puskas, J, Crowley, A, Kosmidou, I, Mehran, R, Ben-Yehuda, O, Généreux, P, Pocock, S, Simonton, C, Stone, G, Kappetein, A

Everolimus-eluting stents or bypass surgery for left main coronary artery disease. by Stone, GW, Sabik, JF, Serruys, PW, Simonton, CA, Généreux, P, Puskas, J, Kandzari, DE, Morice, MC, Lembo, N, Brown, WM, Taggart, DP, Banning, A, Merkely, B, Horkay, F, Boonstra, PW, van Boven, AJ, Ungi, I, Bogáts, G, Mansour, S, Noiseux, N, Sabaté, M, Pomar, J, Hickey, M, Gershlick, A, Buszman, P, Bochenek, A, Schampaert, E, Pagé, P, Dressler, O, Kosmidou, I, Mehran, R, Pocock, SJ, Kappetein, AP

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study by Banning, AP, Serruys, P, De Maria, GL, Ryan, N, Walsh, S, Gonzalo, N, Jan van Geuns, R, Onuma, Y, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, SP, Piek, JJ, Appleby, C, Fath-Ordoubadi, F, Zaman, A, Van Mieghem, NM, Uren, N, Zueco, J, Buszman, P, Iniguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, de Vries, T, Taggart, D, Farooq, V, Spitzer, E, Tijssen, J, Escaned, J

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. by Escaned, J, Collet, C, Ryan, N, De Maria, G, Walsh, S, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, S, Ej West, N, Piek, J, Zaman, A, Fath-Ordoubadi, F, Stables, R, Appleby, C, van Mieghem, N, van Geuns, R, Uren, N, Zueco, J, Buszman, P, Iñiguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, Hanratty, C, Cavalcante, R, Kappetein, A, Taggart, D, van Es, G, Morel, M, de Vries, T, Onuma, Y, Farooq, V, Serruys, P, Banning, A